Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
- 23 January 2009
- Vol. 27 (10) , 1530-1539
- https://doi.org/10.1016/j.vaccine.2009.01.009
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Immunization of Primates with a Newcastle Disease Virus-Vectored Vaccine via the Respiratory Tract Induces a High Titer of Serum Neutralizing Antibodies against Highly Pathogenic Avian Influenza VirusJournal of Virology, 2007
- Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogensProceedings of the National Academy of Sciences, 2007
- Nonsegmented Negative-Strand Viruses as Vaccine VectorsJournal of Virology, 2006
- Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus VectorJournal of Virology, 2006
- Recombinant Newcastle Disease Virus Expressing a Foreign Viral Antigen Is Attenuated and Highly Immunogenic in PrimatesJournal of Virology, 2005
- Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in InfantsThe Journal of Infectious Diseases, 2005
- Induction of Cellular Immune Responses to Simian Immunodeficiency Virus Gag by Two Recombinant Negative-Strand RNA Virus VectorsJournal of Virology, 2004
- A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and ChildrenThe Journal of Infectious Diseases, 1995
- Comparison of Live, Attenuated H1N1 and H3N2 Cold-Adapted and Avian-Human Influenza A Reassortant Viruses and Inactivated Virus Vaccine in AdultsThe Journal of Infectious Diseases, 1988
- ADVANTAGE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A VIRUS OVER INACTIVATED VACCINE FOR A/WASHINGTON/80 (H3N2) WILD-TYPE VIRUS INFECTIONThe Lancet, 1984